Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The inositol phosphate signaling pathway is a fundamental intracellular signaling mechanism that regulates a wide array of cellular processes by converting extracellular signals into secondary messengers (Berridge, M. J., Nature Reviews Molecular Cell Biology, 2009). Upon activation of cell surface receptors, phospholipase C (PLC) hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (StatPearls, "Inositol Phosphate Metabolism", 2023). IP3 subsequently binds to its receptors on the endoplasmic reticulum, triggering the release of sequestered calcium ions into the cytosol, while DAG activates protein kinase C (PKC) (Di Paolo & De Camilli, Nature, 2006). This pathway is essential for maintaining calcium homeostasis, modulating neurotransmitter release, and controlling cell proliferation and apoptosis. Aberrant signaling within this pathway is strongly linked to the pathophysiology of bipolar disorder, epilepsy, and various malignancies, particularly through the PI3K/AKT/mTOR axis (Kalia, M., Journal of Clinical Medicine, 2005). Pharmacological intervention often targets specific enzymes within the pathway, such as inositol monophosphatase (IMPase) by lithium for mood stabilization or phosphoinositide 3-kinases (PI3K) by targeted inhibitors in oncology (Gani D, et al., Nature, 1991). Therapeutic challenges include the pathway's ubiquitous nature, which can lead to significant off-target effects and systemic toxicity when modulated. Understanding the complex feedback loops and crosstalk with other signaling cascades remains a primary focus for developing more selective and safer therapeutic agents.
Inhibition of inositol monophosphatase (IMPase) to deplete inositol levels or inhibition of phosphoinositide kinases (e.g., PI3K) to block downstream signaling cascades.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol phosphate signaling pathway (IP signaling) (IP signaling).